These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 24426932)

  • 21. Treatment of Dupuytren's Contracture With Collagenase: A Systematic Review.
    Sandler AB; Scanaliato JP; Dennis T; Gonzalez Trevizo GA; Raiciulescu S; Nesti L; Dunn JC
    Hand (N Y); 2022 Sep; 17(5):815-824. PubMed ID: 33478271
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Collagenase injections for Dupuytren's disease: prospective cohort study assessing 2-year treatment effect durability.
    Lauritzson A; Atroshi I
    BMJ Open; 2017 Mar; 7(3):e012943. PubMed ID: 28298365
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The use of Collagenase Clostridium Histolyticum in the management of Dupuytren's contracture-outcomes of a pilot study in a District General Hospital setting.
    Murphy LE; Murphy KM; Kilpatrick SM; Thompson NW
    Ulster Med J; 2017 May; 86(2):94-98. PubMed ID: 29535479
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple concurrent collagenase clostridium histolyticum injections to Dupuytren's cords: an exploratory study.
    Coleman S; Gilpin D; Tursi J; Kaufman G; Jones N; Cohen B
    BMC Musculoskelet Disord; 2012 Apr; 13():61. PubMed ID: 22540636
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dupuytren Contracture Recurrence Following Treatment With Collagenase Clostridium histolyticum (CORDLESS [Collagenase Option for Reduction of Dupuytren Long-Term Evaluation of Safety Study]): 5-Year Data.
    Peimer CA; Blazar P; Coleman S; Kaplan FT; Smith T; Lindau T
    J Hand Surg Am; 2015 Aug; 40(8):1597-605. PubMed ID: 26096221
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Injectable collagenase clostridium histolyticum for Dupuytren's contracture.
    Hurst LC; Badalamente MA; Hentz VR; Hotchkiss RN; Kaplan FT; Meals RA; Smith TM; Rodzvilla J;
    N Engl J Med; 2009 Sep; 361(10):968-79. PubMed ID: 19726771
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The efficacy and safety of collagenase clostridium histolyticum in the treatment of patients with moderate Dupuytren's contracture.
    McGrouther DA; Jenkins A; Brown S; Gerber RA; Szczypa P; Cohen B
    Curr Med Res Opin; 2014 Apr; 30(4):733-9. PubMed ID: 24397625
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Collagenase injections for Dupuytren's contracture: prospective cohort study in a public health setting.
    Fletcher J; Tan ESL; Thomas M; Taylor F; Elliott D; Bindra R
    ANZ J Surg; 2019 May; 89(5):573-577. PubMed ID: 30685881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparison of Treatment Outcomes after Collagenase Injection and Percutaneous Needle Fasciotomy for Dupuytren's Contracture: Objective and Subjective Comparisons with a 3-Year Follow-Up.
    Abe Y
    Plast Reconstr Surg; 2020 Jun; 145(6):1464-1474. PubMed ID: 32459776
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Early outcomes of a sequential series of 144 patients with Dupuytren's contracture treated by collagenase injection using an increased dose, multi-cord technique.
    Verheyden JR
    J Hand Surg Eur Vol; 2015 Feb; 40(2):133-40. PubMed ID: 24698852
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Can collagenase effectiveness in Dupuytren's contracture be improved by using ultrasound-guided Injection? A comparative study.
    Aguilella L; Pérez-Giner R; Higueras-Guerrero V; Belloch-Ramos E; Cuenca-Torres M; Juan EL
    J Plast Surg Hand Surg; 2022 Feb; 56(1):23-29. PubMed ID: 33840343
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy and safety of collagenase Clostridium histolyticum injection for Dupuytren's contracture in non-Caucasian Japanese patients (CORD-J Study): the first clinical trial in a non-Caucasian population.
    Hirata H; Tanaka K; Sakai A; Kakinoki R; Ikegami H; Tateishi N
    J Hand Surg Eur Vol; 2017 Jan; 42(1):30-38. PubMed ID: 27313184
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Treatment of Dupuytren's disease with collagenase Clostridium histolyticum].
    Keller M; Arora R; Schmiedle G; Kastenberger T
    Orthopade; 2017 Apr; 46(4):321-327. PubMed ID: 28138723
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy and safety of injectable mixed collagenase subtypes in the treatment of Dupuytren's contracture.
    Badalamente MA; Hurst LC
    J Hand Surg Am; 2007; 32(6):767-74. PubMed ID: 17606053
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clostridium histolyticum as first-line treatment of Dupuytren's disease.
    Hartig-Andreasen C; Schroll L; Lange J
    Dan Med J; 2019 Feb; 66(2):. PubMed ID: 30722822
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Results of needle aponeurotomy for Dupuytren contracture in over 1,000 fingers.
    Pess GM; Pess RM; Pess RA
    J Hand Surg Am; 2012 Apr; 37(4):651-6. PubMed ID: 22464232
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Determining clinically important changes in range of motion in patients with Dupuytren's Contracture: secondary analysis of the randomized, double-blind, placebo-controlled CORD I study.
    Witthaut J; Bushmakin AG; Gerber RA; Cappelleri JC; Le Graverand-Gastineau MP
    Clin Drug Investig; 2011 Nov; 31(11):791-8. PubMed ID: 21967070
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Functional outcome of collagenase injections compared with fasciectomy in treatment of Dupuytren's contracture.
    Naam NH
    Hand (N Y); 2013 Dec; 8(4):410-6. PubMed ID: 24426958
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The risk of skin tear in Dupuytren's disease when treated with collagenase.
    Fagernæs C; Mallet S
    Dan Med J; 2018 May; 65(5):. PubMed ID: 29726315
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.